The low regeneration potential of the central nervous system (CNS) represents a challenge
for the development of new therapeutic strategies. Mesenchymal stem cells (MSCs) have …

Recent pre-clinical and clinical studies have shown that stem cell-based therapies hold
tremendous promise for the treatment of human disease. Mesenchymal stem cells (MSC) …

Hypoxic preconditioning of stem cells and neural progenitor cells has been tested for
promoting cell survival after transplantation. The present investigation examined the …

Context Antibody-based induction therapy plus calcineurin inhibitors (CNIs) reduce acute
rejection rates in kidney recipients; however, opportunistic infections and toxic CNI effects …

Mesenchymal stem cells (MSCs) can differentiate into not only cells of mesodermal
lineages, but also into endodermal and ectodermal derived elements, including neurons …

Although physiological and pathological role of hypoxia have been appreciated in
mammalians for decades however the cellular biology of hypoxia more clarified in the past …

Polycystic ovary syndrome (PCOS) is known as the most common endocrine disorder in
women. Previously, we suggested that human mesenchymal stem cells (MSCs) can reverse …

Introduction Glioblastoma is the most common primary malignant brain tumor, and is
refractory to surgical resection, radiation, and chemotherapy. Human mesenchymal stem …

Umbilical cord blood-derived mononuclear cell (UCB-MNC) transplants improve recovery in
animal spinal cord injury (SCI) models. We transplanted UCB-MNCs into 28 patients with …

Achalasia is an esophageal motility disorder of unknown cause, characterised by
aperistalsis of the esophageal body and impaired lower esophageal sphincter relaxation …